A Stomby1, K Simonyte1, C Mellberg1, M Ryberg1, R H Stimson2, C Larsson3, B Lindahl1, R Andrew2, B R Walker2, T Olsson4. 1. Department for Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden. 2. BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland. 3. 1] Department of Food and Nutrition and Sport Science, University of Gothenburg, Gothenburg, Sweden [2] Department of Food and Nutrition, Umeå University, Umeå, Sweden. 4. 1] Department for Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden [2] Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa.
Abstract
BACKGROUND/ OBJECTIVES: Tissue-specific glucocorticoid metabolism is altered in obesity, and may increase cardiovascular risk. This dysregulation is normalized by short-term calorie restriction and weight loss, an effect that varies with dietary macronutrient composition. However, tissue-specific glucocorticoid metabolism has not been studied during long-term (>6 months) dietary interventions. Therefore our aim was to test whether long-term dietary interventions, either a paleolithic-type diet (PD) or a diet according to Nordic nutrition recommendations (NNR) could normalize tissue-specific glucocorticoid metabolism in overweight and obese women. SUBJECTS/ METHODS: Forty-nine overweight/obese postmenopausal women were randomized to a paleolithic diet or a diet according to NNR for 24 months. At baseline, 6 and 24 months anthropometric measurements, insulin sensitivity, excretion of urinary glucocorticoid metabolites in 24-hour collections, conversion of orally administered cortisone to plasma cortisol and transcript levels of 11β hydroxysteroid dehydrogenase type 1 (11βHSD1) in subcutaneous adipose tissue were studied. RESULTS: Both diet groups achieved significant and sustained weight loss. Weight loss with the PD was greater than on NNR diet after 6 months (P<0.001) but similar at 24 months. Urinary measurement of 5α-reductase activity was increased after 24 months in both groups compared with baseline (P<0.001). Subcutaneous adipose tissue 11βHSD1 gene expression decreased at 6 and 24 months in both diet groups (P=0.036). Consistent with increased liver 11βHSD1, conversion of oral cortisone to cortisol increased at 6 months (P=0.023) but was unchanged compared with baseline by 24 months. CONCLUSIONS: Long-term weight loss in postmenopausal women has tissue-specific and time-dependent effects on glucocorticoid metabolism. This may alter local-tissue cortisol exposure contributing to improved metabolic function during weight loss.
BACKGROUND/ OBJECTIVES: Tissue-specific glucocorticoid metabolism is altered in obesity, and may increase cardiovascular risk. This dysregulation is normalized by short-term calorie restriction and weight loss, an effect that varies with dietary macronutrient composition. However, tissue-specific glucocorticoid metabolism has not been studied during long-term (>6 months) dietary interventions. Therefore our aim was to test whether long-term dietary interventions, either a paleolithic-type diet (PD) or a diet according to Nordic nutrition recommendations (NNR) could normalize tissue-specific glucocorticoid metabolism in overweight and obese women. SUBJECTS/ METHODS: Forty-nine overweight/obese postmenopausal women were randomized to a paleolithic diet or a diet according to NNR for 24 months. At baseline, 6 and 24 months anthropometric measurements, insulin sensitivity, excretion of urinary glucocorticoid metabolites in 24-hour collections, conversion of orally administered cortisone to plasma cortisol and transcript levels of 11β hydroxysteroid dehydrogenase type 1 (11βHSD1) in subcutaneous adipose tissue were studied. RESULTS: Both diet groups achieved significant and sustained weight loss. Weight loss with the PD was greater than on NNR diet after 6 months (P<0.001) but similar at 24 months. Urinary measurement of 5α-reductase activity was increased after 24 months in both groups compared with baseline (P<0.001). Subcutaneous adipose tissue 11βHSD1 gene expression decreased at 6 and 24 months in both diet groups (P=0.036). Consistent with increased liver 11βHSD1, conversion of oral cortisone to cortisol increased at 6 months (P=0.023) but was unchanged compared with baseline by 24 months. CONCLUSIONS: Long-term weight loss in postmenopausal women has tissue-specific and time-dependent effects on glucocorticoid metabolism. This may alter local-tissue cortisol exposure contributing to improved metabolic function during weight loss.
Authors: E Rask; T Olsson; S Söderberg; R Andrew; D E Livingstone; O Johnson; B R Walker Journal: J Clin Endocrinol Metab Date: 2001-03 Impact factor: 5.958
Authors: Alexandra M Johnstone; Peter Faber; Ruth Andrew; Eileen R Gibney; Marinos Elia; Gerald Lobley; R James Stubbs; Brian R Walker Journal: Eur J Endocrinol Date: 2004-02 Impact factor: 6.664
Authors: Roland H Stimson; Alexandra M Johnstone; Natalie Z M Homer; Deborah J Wake; Nicholas M Morton; Ruth Andrew; Gerald E Lobley; Brian R Walker Journal: J Clin Endocrinol Metab Date: 2007-09-04 Impact factor: 5.958
Authors: S A Lottenberg; D Giannella-Neto; H Derendorf; M Rocha; A Bosco; S V Carvalho; A E Moretti; A C Lerário; B L Wajchenberg Journal: Int J Clin Pharmacol Ther Date: 1998-09 Impact factor: 1.366
Authors: Jeremy W Tomlinson; Joanne Finney; Christopher Gay; Beverly A Hughes; Susan V Hughes; Paul M Stewart Journal: Diabetes Date: 2008-07-15 Impact factor: 9.461
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-08-21
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-05-19